MYO/myoglobin flex (10444907)
Ended Awarded
- Contract number
- W81XWH22F0081
- Awardee
-
Siemens Healthcare Diagnostics Inc. UEI GC14SNHB3JN1 Part of Siemens Aktiengesellschaft
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $8,701
Award facts
- Contract value 100% obligated
- $8,701.11 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- 2330 Stanley Rd, Fort Sam Houston, TX 78234, USA
Award details come from SAM.gov/FPDS.
About this award
This contract award is a Blanket Purchase Agreement call issued by Medical Command (a Defense agency component) to Siemens Healthcare Diagnostics Inc. for myoglobin flex diagnostic services, valued at $8,701.11 with a firm fixed price structure. The contract was awarded on April 26, 2022, with an ultimate completion date of April 29, 2022, and performance will take place at Fort Sam Houston, Texas. This BPA call represents a task order issued under an existing indefinite delivery vehicle, enabling the Department of Defense medical facilities to procure diagnostic testing supplies and services without conducting a separate competitive solicitation. No socioeconomic set-aside was applied to this award.
Siemens Healthcare Diagnostics Inc., a subsidiary of German-based Siemens Aktiengesellschaft and headquartered in Tarrytown, New York, is a leading provider of in vitro diagnostic solutions and laboratory services to federal healthcare agencies. The company specializes in manufacturing diagnostic equipment, laboratory analyzers, reagents, and consumables, with established contracts across the Department of Veterans Affairs, Defense Health Agency, Indian Health Service, and other federal medical facilities. This myoglobin flex award reflects Siemens' ongoing support of clinical laboratory operations within the Defense Health Agency's medical command structure, providing diagnostic testing capabilities essential for point-of-care and laboratory-based clinical operations at military medical facilities.
Quick answers
Who was awarded contract W81XWH22F0081?
W81XWH22F0081 was awarded to Siemens Healthcare Diagnostics Inc. by Medical Command (Department of the Army) on April 26, 2022.
How much is contract W81XWH22F0081 worth?
The government has obligated $8,701 on W81XWH22F0081.
Is contract W81XWH22F0081 an order under another contract?
Yes. W81XWH22F0081 is a BPA call under W81XWH22A0003, a blanket purchase agreement.
Was contract W81XWH22F0081 competed?
The extent of competition for W81XWH22F0081 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award